Selected article for: "activity result and low activity"
Author: Morokutti-Kurz, Martina; Graf, Christine; Prieschl-Grassauer, Eva
Title: Amylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or carrageenan lozenges as active treatments for sore throat
  • Document date: 2017_2_28
    • ID: q5j3vcfm_45
    Snippet: From all AMC/DCBA/HR containing lozenges tested against hCoV OC43 the following were chosen to be further evaluated in various replication inhibition assays due to the following considerations: lozenges #3 and #5 both contain AMC/ DCBA as active ingredients at a similar pH, namely 2.2 and 2.3. Nonetheless, only lozenge #5 was active against hCoV OC43, wherefore it was included into the HRV and Coxsackievirus A10 experiments. To exclude the possib.....
    Document: From all AMC/DCBA/HR containing lozenges tested against hCoV OC43 the following were chosen to be further evaluated in various replication inhibition assays due to the following considerations: lozenges #3 and #5 both contain AMC/ DCBA as active ingredients at a similar pH, namely 2.2 and 2.3. Nonetheless, only lozenge #5 was active against hCoV OC43, wherefore it was included into the HRV and Coxsackievirus A10 experiments. To exclude the possibility that a potential antiviral activity is rather a result of the low pH than of the active ingredients, lozenge #4, with the same active agents but a pH of 5.8, was included into the test series. Lozenge #2, with a pH of 5 was tested as it is the only lozenge that contains HR.

    Search related documents:
    Co phrase search for related documents
    • active agent and replication inhibition: 1
    • active agent and test series: 1
    • active ingredient and antiviral activity: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • antiviral activity and low result: 1
    • antiviral activity and potential antiviral activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral activity and replication inhibition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral activity and replication inhibition assay: 1, 2
    • antiviral activity and test series: 1
    • potential antiviral activity and replication inhibition: 1, 2, 3, 4, 5